Adam Vogel
Stock Analyst at Craig-Hallum
(4.21)
# 1,440
Out of 4,457 analysts
31
Total ratings
72%
Success rate
26.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Adam Vogel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MPLT MapLight Therapeutics | Maintained: Buy | $43 → $40 | $34.30 | +16.62% | 2 | Jun 23, 2026 | |
| APGE Apogee Therapeutics | Downgraded: Hold | $114 → $135 | $132.61 | +1.89% | 6 | Jun 22, 2026 | |
| PEPG PepGen | Initiated Coverage: Buy | $11 | $1.78 | +517.98% | 1 | Jun 16, 2026 | |
| IMNM Immunome | Rated: Buy | $36 | $21.04 | +71.10% | 8 | Jun 11, 2026 | |
| LBRX LB Pharmaceuticals | Rated: Buy | $36 | $32.64 | +10.29% | 4 | Jun 11, 2026 | |
| DSGN Design Therapeutics | Rated: Buy | $15 → $22 | $14.24 | +54.49% | 4 | May 19, 2026 | |
| ACRS Aclaris Therapeutics | Maintained: Buy | $10 | $5.02 | +99.20% | 5 | May 7, 2026 | |
| HIT Health In Tech | Maintained: Buy | n/a | $1.01 | - | 1 | Apr 10, 2026 |
MapLight Therapeutics
Jun 23, 2026
Maintained: Buy
Price Target: $43 → $40
Current: $34.30
Upside: +16.62%
Apogee Therapeutics
Jun 22, 2026
Downgraded: Hold
Price Target: $114 → $135
Current: $132.61
Upside: +1.89%
PepGen
Jun 16, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $1.78
Upside: +517.98%
Immunome
Jun 11, 2026
Rated: Buy
Price Target: $36
Current: $21.04
Upside: +71.10%
LB Pharmaceuticals
Jun 11, 2026
Rated: Buy
Price Target: $36
Current: $32.64
Upside: +10.29%
Design Therapeutics
May 19, 2026
Rated: Buy
Price Target: $15 → $22
Current: $14.24
Upside: +54.49%
Aclaris Therapeutics
May 7, 2026
Maintained: Buy
Price Target: $10
Current: $5.02
Upside: +99.20%
Health In Tech
Apr 10, 2026
Maintained: Buy
Price Target: n/a
Current: $1.01
Upside: -